Posts by Jennifer S. Temel, MD
-
Revolutionizing Palliative Care Delivery and Access to Improve Outcomes for Patients and Caregivers
Research at Massachusetts General Hospital is shifting how integrated palliative and oncology care is delivered to support patients with cancer and caregivers.
-
Educational Video About Hospice Linked to Higher Utilization Rate, Longer Hospice Stay
In a randomized trial, patients with advanced cancer who were assigned to view an educational video about hospice were more likely than controls to use hospice, and their hospice stay was longer.
-
Psychosocial Intervention Promising for Caregivers of Patients Undergoing Stem Cell Transplantation
In a randomized, controlled trial conducted by the Mass General Cancer Center, a psychosocial intervention for caregivers of patients scheduled to undergo hematopoietic stem cell transplantation was feasible and showed promise for improving caregiving burden, quality of life, mood, self-efficacy and coping skills.
-
Integrated Geriatric/Palliative Care Intervention Promising for Older Adults with Cancer
In a pilot randomized, controlled trial, incorporation of geriatricians into outpatient oncology care was feasible and helpful for older adults.
Biography
Jennifer Temel, MD, is professor of Medicine at Harvard Medical School, clinical director of Thoracic Oncology at Massachusetts General Hospital and co-director of the Cancer Outcomes Research and Education Program at the Mass General Cancer Center, and co-leader of the Dana Farber/Harvard Cancer Center Outcomes Research Program. Dr. Temel’s research focuses on optimizing palliative and supportive care for patients with cancer and their families. Her major research interest includes the study of early, integrated palliative care for patients with advanced cancers.
Mass General Cancer Center
An integral part of one of the world’s most distinguished academic medical centers, the Massachusetts General Hospital Cancer Center is among the leading cancer care providers in the United States.
